Literature DB >> 26036448

Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles.

Yoo Chun Kim1, Kyung Hee Oh2, Henry F Edelhauser3, Mark R Prausnitz4.   

Abstract

In this work, we tested the hypothesis that particles injected into the suprachoroidal space can be localized at the site of injection or broadly distributed throughout the suprachoroidal space by controlling polymeric formulation properties. Single hollow microneedles were inserted into the sclera of New Zealand White rabbits and injected non-biodegradable fluorescently tagged nanoparticles and microparticles suspended in polymeric formulations into the suprachoroidal space of the eye. When formulated in saline, the particles were distributed over 29-42% of the suprachoroidal space immediately after injection. To spread particles over larger areas of the choroidal surface, addition of hyaluronic acid to make moderately non-Newtonian solutions increased particle spread to up to 100% of the suprachoroidal space. To localize particles at the site of injection adjacent to the ciliary body, strongly non-Newtonian polymer solutions localized particles to 8.3-20% of the suprachoroidal space, which exhibited a small increase in area over the course of two months. This study demonstrates targeted particle delivery within the suprachoroidal space using polymer formulations that spread particles over the whole choroidal surface or localized them adjacent to the ciliary body after injection.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Eye; Microneedles; Ocular drug delivery; Particle formulation; Suprachoroidal space

Mesh:

Substances:

Year:  2015        PMID: 26036448      PMCID: PMC4604027          DOI: 10.1016/j.ejpb.2015.05.020

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  32 in total

1.  Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.

Authors:  Samirkumar R Patel; Damian E Berezovsky; Bernard E McCarey; Vladimir Zarnitsyn; Henry F Edelhauser; Mark R Prausnitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-01       Impact factor: 4.799

Review 2.  In situ forming implants - an attractive formulation principle for parenteral depot formulations.

Authors:  Sabine Kempe; Karsten Mäder
Journal:  J Control Release       Date:  2012-04-18       Impact factor: 9.776

Review 3.  Use of viscoelastic solutions in ophthalmology: a review of physical properties and long-term effects.

Authors:  F H Silver; J LiBrizzi; D Benedetto
Journal:  J Long Term Eff Med Implants       Date:  1992

4.  Useful adjuncts for vitreoretinal surgery.

Authors:  J G Gross; W R Freeman; M H Goldbaum; T L Mendez
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

5.  Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide.

Authors:  J B Jonas; R Degenring; U Vossmerbauemer; B Kamppeter
Journal:  Eur J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.597

6.  Complications of intravitreal injection of triamcinolone acetonide.

Authors:  Abdullah Ozkiriş; Kuddusi Erkiliç
Journal:  Can J Ophthalmol       Date:  2005-02       Impact factor: 1.882

7.  Prospective survey of adverse reactions to topical antiglaucoma medications in a hospital population.

Authors:  R Bhatt; K W Whittaker; S Appaswamy; A Desai; A Fitt; S Sandramouli
Journal:  Eye (Lond)       Date:  2005-04       Impact factor: 3.775

8.  Postoperative intraocular pressure changes with use of different viscoelastics.

Authors:  V K Dada; N Sindhu; M S Sachdev
Journal:  Ophthalmic Surg       Date:  1994-08

9.  Prostaglandin E2 binding site distribution and subtype classification in the rabbit iris-ciliary body.

Authors:  S Csukas; P Bhattacherjee; L Rhodes; C A Paterson
Journal:  Prostaglandins       Date:  1992-09

Review 10.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

View more
  19 in total

Review 1.  Nanocrystal for ocular drug delivery: hope or hype.

Authors:  Om Prakash Sharma; Viral Patel; Tejal Mehta
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

2.  Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.

Authors:  Bryce Chiang; Nitin Venugopal; Henry F Edelhauser; Mark R Prausnitz
Journal:  Exp Eye Res       Date:  2016-10-11       Impact factor: 3.467

3.  Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.

Authors:  Jae Hwan Jung; Bryce Chiang; Hans E Grossniklaus; Mark R Prausnitz
Journal:  J Control Release       Date:  2018-03-02       Impact factor: 9.776

Review 4.  Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.

Authors:  I Bravo-Osuna; V Andrés-Guerrero; P Pastoriza Abal; I T Molina-Martínez; R Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 5.  Targeting drug delivery within the suprachoroidal space.

Authors:  Jae Hwan Jung; J Jeremy Chae; Mark R Prausnitz
Journal:  Drug Discov Today       Date:  2019-04-03       Impact factor: 7.851

Review 6.  The suprachoroidal space as a route of administration to the posterior segment of the eye.

Authors:  Bryce Chiang; Jae Hwan Jung; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2018-03-12       Impact factor: 15.470

7.  Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries.

Authors:  Bryce Chiang; Yoo Chun Kim; Henry F Edelhauser; Mark R Prausnitz
Journal:  Exp Eye Res       Date:  2016-03-11       Impact factor: 3.467

8.  Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma.

Authors:  B Chiang; Y C Kim; A C Doty; H E Grossniklaus; S P Schwendeman; M R Prausnitz
Journal:  J Control Release       Date:  2016-02-28       Impact factor: 9.776

9.  Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targeting.

Authors:  Jae Hwan Jung; Sanghyun Park; J Jeremy Chae; Mark R Prausnitz
Journal:  Exp Eye Res       Date:  2019-10-01       Impact factor: 3.467

Review 10.  Non-transdermal microneedles for advanced drug delivery.

Authors:  KangJu Lee; Marcus J Goudie; Peyton Tebon; Wujin Sun; Zhimin Luo; Junmin Lee; Shiming Zhang; Kirsten Fetah; Han-Jun Kim; Yumeng Xue; Mohammad Ali Darabi; Samad Ahadian; Einollah Sarikhani; WonHyoung Ryu; Zhen Gu; Paul S Weiss; Mehmet R Dokmeci; Nureddin Ashammakhi; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2019-12-16       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.